<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37343522</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>23</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>04</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2666-3791</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>20</Day></PubDate></JournalIssue><Title>Cell reports. Medicine</Title><ISOAbbreviation>Cell Rep Med</ISOAbbreviation></Journal><ArticleTitle>Targeting gasdermin E in neurodegenerative diseases.</ArticleTitle><Pagination><StartPage>101075</StartPage><MedlinePgn>101075</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">101075</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.xcrm.2023.101075</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2666-3791(23)00194-5</ELocationID><Abstract><AbstractText>Neel et&#xa0;al. identified pathophysiologic clues linking gasdermin-E (GSDME) with frontotemporal dementia and amyotrophic lateral sclerosis.<sup>1</sup> Therapeutic studies targeting GSDME may provide a viable approach for neurodegenerative diseases.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 The Author(s). Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Zhi Dong</ForeName><Initials>ZD</Initials><AffiliationInfo><Affiliation>National Neuroscience Institute of Singapore, 11 Jalan Tan Tock Seng, Singapore, 30843, Singapore; Signature Research Program in Neuroscience and Behavioral Disorders, Duke-NUS Medical School, 8 College Road, Singapore, 169857, Singapore. Electronic address: zhidong.zhou@duke-nus.edu.sg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yi</LastName><ForeName>Ling Xiao</ForeName><Initials>LX</Initials><AffiliationInfo><Affiliation>National Neuroscience Institute of Singapore, 11 Jalan Tan Tock Seng, Singapore, 30843, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Eng King</ForeName><Initials>EK</Initials><AffiliationInfo><Affiliation>National Neuroscience Institute of Singapore, 11 Jalan Tan Tock Seng, Singapore, 30843, Singapore; Department of Neurology, Singapore General Hospital, Outram Road, Singapore, 169608, Singapore; Signature Research Program in Neuroscience and Behavioral Disorders, Duke-NUS Medical School, 8 College Road, Singapore, 169857, Singapore. Electronic address: tan.eng.king@sgh.com.sg.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cell Rep Med</MedlineTA><NlmUniqueID>101766894</NlmUniqueID><ISSNLinking>2666-3791</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000094524">Gasdermins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094524" MajorTopicYN="N">Gasdermins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Declaration of interests The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>5</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>5</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>23</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>22</Day><Hour>1</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>21</Day><Hour>18</Hour><Minute>17</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37343522</ArticleId><ArticleId IdType="pmc">PMC10313929</ArticleId><ArticleId IdType="doi">10.1016/j.xcrm.2023.101075</ArticleId><ArticleId IdType="pii">S2666-3791(23)00194-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Neel D.V., Basu H., Gunner G., Bergstresser M.D., Giadone R.M., Chung H., Miao R., Chou V., Brody E., Jiang X., et al. Gasdermin-E mediates mitochondrial damage in axons and neurodegeneration. Neuron. 2023;111:1222&#x2013;1240.e9. doi: 10.1016/j.neuron.2023.02.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2023.02.019</ArticleId><ArticleId IdType="pmc">PMC10121894</ArticleId><ArticleId IdType="pubmed">36917977</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia S., Hollingsworth L.R., 4th, Wu H. Mechanism and regulation of Gasdermin-mediated cell death. Cold Spring Harb. Perspect. Biol. 2020;12 doi: 10.1101/cshperspect.a036400.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a036400</ArticleId><ArticleId IdType="pmc">PMC7050592</ArticleId><ArticleId IdType="pubmed">31451512</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y.Q., Peng J.J., Peng J., Luo X.J. The deafness gene GSDME: its involvement in cell apoptosis, secondary necrosis, and&#xa0;cancers. Naunyn-Schmiedeberg&#x2019;s Arch. Pharmacol. 2019;392:1043&#x2013;1048. doi: 10.1007/s00210-019-01674-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00210-019-01674-7</ArticleId><ArticleId IdType="pubmed">31230091</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers C., Alnemri E.S. Gasdermins: novel mitochondrial pore-forming proteins. Mol. Cell. Oncol. 2019;6 doi: 10.1080/23723556.2019.1621501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23723556.2019.1621501</ArticleId><ArticleId IdType="pmc">PMC6736162</ArticleId><ArticleId IdType="pubmed">31528697</ArticleId></ArticleIdList></Reference><Reference><Citation>Sehlin D., Fang X.T., Meier S.R., Jansson M., Syv&#xe4;nen S. Pharmacokinetics, biodistribution and brain retention of a bispecific antibody-based PET radioligand for imaging of amyloid-&#x3b2;. Sci. Rep. 2017;7 doi: 10.1038/s41598-017-17358-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-17358-2</ArticleId><ArticleId IdType="pmc">PMC5722892</ArticleId><ArticleId IdType="pubmed">29222502</ArticleId></ArticleIdList></Reference><Reference><Citation>Caruana M., H&#xf6;gen T., Levin J., Hillmer A., Giese A., Vassallo N. Inhibition and disaggregation of &#x3b1;-synuclein oligomers by natural polyphenolic compounds. FEBS Lett. 2011;585:1113&#x2013;1120. doi: 10.1016/j.febslet.2011.03.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2011.03.046</ArticleId><ArticleId IdType="pubmed">21443877</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin J.W., Fan X., del Cid-Pellitero E., Liu X.-X., Zhou L., Dai C., Gibbs E., He W., Li H., Wu X., et al. Development of an &#x3b1;-synuclein knockdown peptide and evaluation of its efficacy in Parkinson&#x2019;s disease models. Commun. Biol. 2021;4:232. doi: 10.1038/s42003-021-01746-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-021-01746-6</ArticleId><ArticleId IdType="pmc">PMC7895943</ArticleId><ArticleId IdType="pubmed">33608634</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers C., Erkes D.A., Nardone A., Aplin A.E., Fernandes-Alnemri T., Alnemri E.S. Gasdermin pores permeabilize mitochondria to augment caspase-3 activation during apoptosis and inflammasome activation. Nat. Commun. 2019;10:1689. doi: 10.1038/s41467-019-09397-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-09397-2</ArticleId><ArticleId IdType="pmc">PMC6459836</ArticleId><ArticleId IdType="pubmed">30976076</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>